Mitochondrial complex I NUBPL mutations cause combined dystonia with bilateral striatal necrosis and cerebellar atrophy.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
09 2019
Historique:
received: 18 12 2018
accepted: 18 03 2019
pubmed: 22 3 2019
medline: 18 8 2020
entrez: 22 3 2019
Statut: ppublish

Résumé

The recent advances in genetics have helped to unravel the cause of many dystonia syndromes. With the broadening spectrum of genetically defined dystonia syndromes, distinct clinico-radiological phenotypes are a welcome handle to guide the diagnostic work-up. Exome sequencing was used to elucidate the genetic cause of a syndrome characterized by generalized dystonia, pyramidal and cerebellar involvement, with bilateral striatal necrosis (BSN) and cerebellar atrophy on magnetic resonance imaging. Homozygosity mapping and linkage analysis were used in a supportive role. Known genetic causes of BSN were excluded by use of exome data or Sanger sequencing. Compound heterozygous mutations were identified in the NUBPL gene in a small UK kindred. The gene lay in a region of positive linkage and segregated with disease in a family of six individuals. NUBPL mutations cause early onset, autosomal recessive generalized dystonia with cerebellar ataxia, pyramidal signs, preserved cognition and a distinct magnetic resonance imaging appearance with BSN and cerebellar atrophy.

Sections du résumé

BACKGROUND AND PURPOSE
The recent advances in genetics have helped to unravel the cause of many dystonia syndromes. With the broadening spectrum of genetically defined dystonia syndromes, distinct clinico-radiological phenotypes are a welcome handle to guide the diagnostic work-up.
METHODS
Exome sequencing was used to elucidate the genetic cause of a syndrome characterized by generalized dystonia, pyramidal and cerebellar involvement, with bilateral striatal necrosis (BSN) and cerebellar atrophy on magnetic resonance imaging. Homozygosity mapping and linkage analysis were used in a supportive role. Known genetic causes of BSN were excluded by use of exome data or Sanger sequencing.
RESULTS
Compound heterozygous mutations were identified in the NUBPL gene in a small UK kindred. The gene lay in a region of positive linkage and segregated with disease in a family of six individuals.
CONCLUSION
NUBPL mutations cause early onset, autosomal recessive generalized dystonia with cerebellar ataxia, pyramidal signs, preserved cognition and a distinct magnetic resonance imaging appearance with BSN and cerebellar atrophy.

Identifiants

pubmed: 30897263
doi: 10.1111/ene.13956
pmc: PMC6767441
doi:

Substances chimiques

Mitochondrial Proteins 0
NUBPL protein, human 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1240-1243

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT089698/Z/09/Z
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Nat Genet. 2010 Oct;42(10):851-8
pubmed: 20818383
Hum Mutat. 2012 Feb;33(2):411-8
pubmed: 22072591
Neurology. 2013 Apr 23;80(17):1577-83
pubmed: 23553477
Eur J Neurol. 2015 Apr;22(4):610-7
pubmed: 25643588

Auteurs

B Balint (B)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.

G Charlesworth (G)

Department of Neurology, Charing Cross Hospital, London, UK.

M Stamelou (M)

Second Department of Neurology, Attiko Hospital, University of Athens, Athens, Greece.
Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece.

L Carr (L)

Neuroscience Department, GOSH, London, UK.

N E Mencacci (NE)

Department of Neurology, Northwestern University, Chicago, IL, USA.

N W Wood (NW)

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.

K P Bhatia (KP)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH